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Abstract
Introduction
Patients with cancer frequently suffer from emotional distress, characterized by psychologi-
cal symptoms such as anxiety or depression. The presence of psychological symptoms com-
bined with the complex nature of oncology processes can negatively impact patients’ quality
of life. We aimed to determine the impact of a relaxation protocol on improving quality of life
in a sample of oncological patients treated in the Spanish National Public Health System.
Materials and methods
We conducted a multicenter interventional study without a control group. In total, 272
patients with different oncologic pathologies and showing symptoms of anxiety were
recruited from 10 Spanish public hospitals. The intervention comprised abbreviated progres-
sive muscle relaxation training, according to Bernstein and Borkovec. This was followed by
weekly telephone calls to each patient over a 1-month period. We collected sociodemo-
graphic variables related to the disease process, including information about mental health
and the intervention. Patients’ quality of life was assessed using the Functional Assessment
of Cancer Therapy-General (FACT-G) questionnaire. Bivariate and univariate analyses
were performed, along with an analysis of multiple correspondences to identify subgroups
of patients with similar variations on the FACT-G.
Results
Patients showed statistically significant improvements on the FACT-G overall score
(W = 16806; p<0.001), with an initial mean score of 55.33±10.42 and a final mean score
of 64.49±7.70. We also found significant improvements for all subscales: emotional well-
being (W = 13118; p<0.001), functional wellbeing (W = 16155.5; p<0.001), physical well-
being (W = 8885.5; p<0.001), and social and family context (W = −1840; p = 0.037).
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Conclusions
Patients with cancer who learned and practiced abbreviated progressive muscle relaxation
experienced improvement in their perceived quality of life as measured by the FACT-G. Our
findings support a previous assumption that complementary techniques (including relaxa-
tion techniques) are effective in improving the quality of life of patients with cancer.
Introduction
The complexity of cancer processes and treatment is associated with emotional distress [1–3].
Consequently, many patients experience symptoms of anxiety and/or depression [4,5].
Approximately one-third of patients with cancer are estimated to suffer from some type of
mental disorder during the course of active treatment (20% of patients suffer from anxiety and
13% show signs of depression) [6,7]. Fatigue is also present in 50–90% of patients and pain in
20–50% [8], with pain experienced by 90% of patients when cancer is at advanced stages [9].
In addition, nausea is experienced by around 42% of patients with cancer [10]. These cancer-
associated symptoms negatively affect patients’ quality of life; therefore, implementation of
interventions to improve these complaints should be a primary objective of health services.
In this context, complementary and alternative medicine (CAM) is gaining increased
importance as it contributes to improving the emotional state, fatigue, quality of life, and
adherence to treatment in patients who suffer from different types of tumors [11–15]. The
National Centre of Complementary and Alternative Medicine notes CAM therapies can be
classified into two categories: those related to natural products (e.g., vitamins and minerals)
and those involving mind-body practices (e.g., acupuncture, massage, meditation, movement
therapy, yoga, hypnotherapy, healing touch, and muscle relaxation) [16].
The physiological foundations of muscle relaxation techniques place the origin of negative
emotional states with an excess of neuromuscular tension [17]. By achieving muscle relaxation,
relaxation of the mind can be achieved, along with a general state of wellbeing. There is evi-
dence supporting that therapies involving relaxation interventions (i.e., muscle relaxation, acu-
puncture, yoga, reiki, etc) may improve the quality of life of cancer patients; however, these
techniques require several learning sessions, greater follow-up over time, and do not always
achieve an increase in quality of life [11,18–25]. These techniques have been used for control-
ling anxiety in different contexts, including pregnant women [26], fear of dentists [27], pulmo-
nary hypertension [28], and schizophrenia [29]. Improving the quality of life of patients with
cancer requires the development of interventions applicable to this unique population. There-
fore, this study aimed to determine the impact of a relaxation protocol in improving quality of
life in a sample of oncological patients treated in the Spanish National Public Health System.
Materials and methods
Design
We used a multicenter pre-post intervention study design without a control group.
Participants
This study was performed in the oncological units of 10 hospitals belonging to the Spanish
National Public Health System between November 1, 2014 and October 1, 2015. Participation
of the hospitals was gradual throughout the study period. In all cases, patient recruitment
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began after authorization by the ethics committee corresponding to each hospital. The study
population included patients with any type of cancer (oncological and/or hematological malig-
nances), of both sexes, older than 18 years, who agreed to participate in the study, and who
showed anxiety, muscle tension, sleeping difficulties, sadness, and/or anxiety attacks. Patients
were excluded if they showed severe cognitive or physical impairment, were unable to under-
stand or reproduce the relaxation technique used in the intervention, or were in a terminal
condition with a prognosis of imminent death. Although no adverse effects have been reported
following use of this technique, it is important to highlight that such techniques should not be
considered a substitute for medical treatment. Patients suffering from hallucinations, delirium
or other psychotic symptoms were also excluded from this study, as the exercises used in the
intervention may lead to potentially unpleasant extracorporeal sensations in those patients.
Patient recruitment was conducted in the oncology units of participating hospitals via posters,
informative flyers, and information provided to the health professionals caring for the patients
(i.e., oncologists, nurses, and psychologists). In total, 272 patients from the oncological services
of the participating hospitals satisfied all eligibility criteria and agreed to participate. Six
patients (2%) did not practice the technique at home, and were excluded from the analysis
(Fig 1).
Data collection
Data were collected using the Functional Assessment of Cancer Therapy-General (FACT-G)
questionnaire and an ad hoc data collection notebook. The FACT-G comprises 27 items fea-
turing general questions divided into four quality of life domains: physical wellbeing, social/
family wellbeing, emotional wellbeing, and functional wellbeing [30]. Item scores range from
0–4 points. The total score ranges from 0–108 points, with higher scores indicating better qual-
ity of life. The FACT-G is considered appropriate for use with patients suffering from any type
of cancer [31]. A systematic review found that the FACT-G total and subscale scores had excel-
lent reliability, with Cronbach’s alpha values ranging from 0.71–0.88 [32]. In the present study
we used the validated Spanish version of the FACT-G [33].
Information collected in the data collection notebook included: 1) sociodemographic and
medical characteristics (medical center, age, gender, marital status, children, and educational
level); 2), oncological process (cancer diagnosis, cancer therapy—chemotherapy, radiotherapy,
hormone therapy, biological therapy, and surgery—side effects of cancer treatment, cancer
pain, and analgesic use); 3) mental health issues (use of anxiolytics/hypnotics/antidepressants,
comorbid psychiatric diagnoses, psychiatric-psychological treatment, and use of relaxation
techniques); and 4) other variables related to the intervention, such as symptoms that moti-
vated participation in the study and questions including “Have you practiced the technique at
home?” and “How many times do you practice the technique in a week?”
This was followed by weekly telephone calls to each patient over a 1-month period.
Intervention
All participants received an initial guided session to learn abbreviated progressive muscle
relaxation training, following Bernstein and Borkovec [34]. This technique consists of contrac-
tion and subsequent relaxation of all muscle groups sequentially. In a sitting position and with
their eyes closed, participants were instructed to contract and relax the muscles of their hands,
forearms, face, neck, shoulders, abdomen, and lower limbs in turn. During implementation of
the technique, patients were recommended to perform normal breathing. The initial sessions
were conducted individually or in groups, according to the patient’s condition. To unify crite-
ria and reduce possible inter-examiner bias, researchers who conducted the sessions were fully
Muscle relaxation in cancer patients
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trained regarding the study selection criteria, information provided to participants, data collec-
tion procedures, and application of the technique. All researchers were instructed in, and
received written guidance about, conducting the relaxation session. The main researcher was
present at the first treatment session at all hospital centers to homogenize all aspects of the
intervention. A pilot test was performed with the first 30 participating patients. Patients per-
formed the technique in a sitting position, and the sessions were conducted in rooms fur-
nished with armchairs, cushions, pleasant lighting, and a quiet environment. Each session
lasted approximately 60 minutes and was divided into four parts: 1) explanation of the charac-
teristics of the abbreviated progressive muscle relaxation training [34]; 2) application of a
relaxation session; 3) answering any questions; and 4) data collection using the self-adminis-
tered FACT-G and data collection notebook.
At the end of the session, patients were provided with information about the intervention,
including a brief description of the session based on text and images to support them in per-
forming the technique at their own homes.
Ethical considerations
This study was approved by the Ethical Committee of Clinical Research accredited by the Min-
istry of Health, Social Services and Equality (Spain) for each center involved in the study (Uni-
versity Hospital of Getafe, 06/26/2014; Puerta del Hierro-Majadahonda, 07/24/2014;
Foundation Alcorcon, 11/03/2014; Fuenlabrada, 12/03/2014; Bellvitge, 09/10/2014; Salamanca,
07/18/2014; Navarra, 03/27/2015; Hospital Germans Trias i Pujol, 11/21/2014; and Cantabria
Fig 1. Flowchart of study participants.
https://doi.org/10.1371/journal.pone.0184147.g001
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08/01/2014) [35]. This trial is registered with ISRCTN, under registration number 81335752.
Clinical trial registration was delayed as this study was classified by the Spanish Agency of
Medicine as an Observational Study No Epa, and therefore should not be included in the Span-
ish Registry of Clinical Studies. In addition, the study sponsor considered this work as a behav-
ioral intervention rather than a clinical trial because of the lack of drugs, biologics, or devices.
The authors confirm that there are no ongoing or related trials for this intervention. All proce-
dures were conducted according to the Declaration of Helsinki [36]. All study participants
provided written informed consent after they received appropriate information regarding the
study aims, potential benefits and possible risks. Data were treated anonymously and confi-
dentially according to the Spanish Personal Data Protection Act [37].
Sample size calculation
The sample size was calculated using EPIDATA version 4.1. As the inclusion of different hos-
pitals was gradual throughout the study, we estimated the sample size based on an infinite pop-
ulation-based sample. With a 95% confidence level, an expected proportion of 20% of anxiety
disorders in the cancer population [6,7], and a maximum error of estimation of 5%, the esti-
mated sample size was 246 patients. An expected loss rate of 5% was assumed; therefore, the
final estimated sample size was 259 patients.
Data analysis
Statistical analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC, USA).
The level of statistical significance was set at 0.05. A descriptive univariate analysis to calculate
the total score and percentage for each category was performed for categorical variables. Basic
descriptive statistics and the Wilcoxon signed-rank test (W) were performed for quantitative
variables. For the bivariate analyses, we used the Kruskal-Wallis (KW), chi-square (χ2) or like-
lihood ratio chi-square (G2) (when there are more than 25% of cells with expected counts less
than 5) tests for contingency tables, including variables with low expected counts.
We also performed multiple correspondence analyses [38] to detect groups of patients with
similar progressions based on FACT-G responses. To perform these analyses, we considered
that in each questionnaire item there was a negative, constant, or positive progression accord-
ing to baseline and final scores. Based on this evolution, we considered the active variables as:
GP1, GP6, GS3, GS5, GS6, GS7, GE1, GE2, GE3, GE4, GE5, GF1, GF4, GF6, and GF7 (a mini-
mum of 5% of patients in each type of evolution) (see S1 Table).
From these analyses, we obtained 21 factors which summarized all changes in the sample
(see S2 Table). We also performed a classification defining four clusters of patients with similar
responses (S1 and S2 Figs).
After obtaining the four patient groups, we analyzed which outcomes (among the various
FACT-G items) had a different proportion with regard to the proportion of the sample (hyper-
geometric distribution). Finally, a bivariate analysis of the variation rate of the FACT-G was
performed for each cluster of patients.
Results
Table 1 describes the sociodemographic and medical characteristics of participating patients
for the total sample, and stratified by clusters. No significant differences in sociodemographic
features were observed among clusters, except for having children (G2 = 89; p = 0.031).
More than 90% of patients in each cluster had received chemotherapy, with no significant
differences among the clusters (G2 = 4.44; p = 0.218). However, significant differences were
Muscle relaxation in cancer patients
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Table 1. Sociodemographic and medical characteristics of participating patients for the total sample, and stratified by clusters.
CLUSTER
TOTAL cluster 1 cluster 2 cluster 3 cluster 4 p
N % N % N % N % N %
MEDICAL CENTER
University Hospital Marques de
Valdecilla, Cantabria.
16 6.02 10 6.25 2 9.52 2 3.03 2 10.53
Fundacio´n Alcorco´n Hospital, Madrid. 35 13.16 20 12.50 3 14.29 7 10.61 5 26.32
Getafe University Hospital, Madrid. 17 6.39 14 8.75 1 4.76 — — 2 10.53
Fuenlabrada University Hospital, Madrid. 52 19.55 24 15.00 5 23.81 19 28.79 4 21.05
Catalan Institute of Oncology, Hospital
University of Bellvitge, Barcelona.
35 13.16 20 12.50 3 14.29 10 15.15 2 10.53
Catalan Institute of Oncology, Hospital
University"Germans Trias i Pujol",
Barcelona.
45 16.92 31 19.38 4 19.05 9 13.64 1 5.26
Sierrallana Hospital, Cantabria. 4 1.50 3 1.88 — — 1 1.52 — —
Hospital of Navarra, Navarra. 47 17.67 29 18.13 3 14.29 14 21.21 1 5.26
Hospital of Salamanca, Salamanca. 5 1.88 3 1.88 — — 1 1.52 1 5.26
Puerta de Hierro-Majadahonda University
Hospital, Madrid.
10 3.76 6 3.75 — — 3 4.55 1 5.26
AGE (years) Mean [SD]a
52.56
[11.5] 52.55 [11.57] 50.76 [10.27] 52.36 [10.36] 55.26 [13.85] 0.446*
GENDER
Female 203 76.32 118 73.75 16 76.19 55 83.33 14 73.68 0.460**
Male 63 23.68 42 26.25 5 23.81 11 16.67 5 26.32
MARITAL STATUS
Married 178 66.92 110 68.75 11 52.38 43 65.15 14 73.68
Single 39 14.66 22 13.75 5 23.81 12 18.18 — —
Divorced 11 4.14 8 5.00 1 4.76 2 3.03 — —
Widowed 10 3.76 2 1.25 — — 3 4.55 5 26.32
Separated 11 4.14 7 4.38 2 9.52 2 3.03 — —
Domestic partnership 17 6.39 11 6.88 2 9.52 4 6.06 — —
CHILDREN
No 61 22.93 40 25.00 9 42.86 10 15.15 2 10.53 0.031**
Yes 205 77.07 120 75.00 12 57.14 56 84.85 17 89.47
EDUCATIONAL LEVEL
Elementary 131 49.25 75 46.88 12 57.14 34 51.52 10 52.63 0.736**
Secondary 87 32.71 59 36.88 5 23.81 18 27.27 5 26.32
University 48 18.05 26 16.25 4 19.05 14 21.21 4 21.05
CANCER DIAGNOSIS
Lung 31 11.65 23 14.38 1 4.76 2 3.03 5 26.32
Digestive 36 13.53 17 10.63 3 14.28 10 15.16 6 31.57
Head and neck 5 1.88 2 1.26 1 4.76 2 3.04 — —
Gynecological 139 52.26 81 50.63 14 66.66 38 57.58 6 31.58
Urinary 7 2.63 3 1.88 — — 4 6.06 — —
Hematological malignancies 41 15.41 30 18.78 1 4.76 8 12.13 2 10.52
Others 7 2.63 4 5.51 1 4.76 2 3.04 — —
CANCER THERAPY
Chemotherapy 256 96.24 156 97.50 19 90.48 62 93.94 19 100.00 0.218**
Radiotherapy 121 45.49 69 43.13 10 47.62 35 53.03 7 36.84 0.478***
Hormone therapy 52 19.55 28 17.50 7 33.33 17 25.76 — — 0.006**
Biological therapy 50 18.80 29 18.13 4 19.05 14 21.21 3 15.79 0.938**
Surgery to remove cancer 147 55.26 93 58.13 13 61.90 34 51.52 7 36.84 0.274***
SIDE EFFECTS OF CANCER TREATMENT
No 35 13.16 20 12.50 1 4.76 9 13.64 5 26.32 0.255**
Yes 231 86.84 140 87.50 20 95.24 57 86.36 14 73.68
CANCER PAIN
No 142 53.38 78 48.75 13 61.90 38 57.58 13 68.42 0.242***
Yes 124 46.62 82 51.25 8 38.10 28 42.42 6 31.58
ANALGESICS USE
(Continued)
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detected in patients undergoing hormone therapy, ranging from 17–33% in clusters 1–3, but
none in cluster 4 (G2 = 12.42; p = 0.006).
Patients in cluster 3 who practiced the technique more times a week on average, exhibited
lower levels of pre-session anxiety in all sessions, including the first session (baseline: χ2 =
23.15, p<0.001; first week: χ2 = 18.03, p<0.001; second week: χ2 = 15.04, p = 0.002; third week:
χ2 = 13.44, p = 0.004; fourth week: χ2 = 12.92, p = 0.005). Table 2 displays the evolution rate of
Table 1. (Continued)
CLUSTER
TOTAL cluster 1 cluster 2 cluster 3 cluster 4 p
N % N % N % N % N %
No — — — — — — — — — —
Yes 124 100 82 100.00 8 100.00 28 100.00 6 100.00
ANXIOLYTICS USE
No 182 68.42 109 68.13 13 61.90 47 71.21 13 68.42 0.883
Yes 84 31.58 51 31.88 8 38.10 19 28.79 6 31.58
ANTIDEPRESSANTS USE
No 234 87.97 142 88.75 18 85.71 60 90.91 14 73.68 0.303**
Yes 32 12.03 18 11.25 3 14.29 6 9.09 5 26.32
HYNOTICS USE
No 208 78.20 117 73.13 17 80.95 58 87.88 16 84.21 0.073**
Yes 58 21.80 43 26.88 4 19.05 8 12.12 3 15.79
PSYCHIATRIC DIAGNOSIS
No 259 97.37 154 96.25 21 100.00 65 98.48 19 100.00
Yes 7 2.63 6 3.75 — — 1 1.52 — —
PSYCHIATRIC-PSYCHOLOGICAL TREATMENT
No 261 98.12 156 97.50 21 100.00 65 98.48 19 100.00
Yes 5 1.88 4 2.50 — — 1 1.52 — —
RELAXATION TECHNIQUES
No 261 98.12 155 96.88 21 100.00 66 100.00 19 100.00
Yes 5 1.88 5 3.13 — — — — — —
STUDY INCLUSION SYMPTOMS
Anxiety 261 98.12 159 99.38 21 100.00 65 98.48 16 84.21 0.014**
Insomnia 51 19.17 28 17.50 7 33.33 11 16.67 5 26.32 0.321**
Sadness 15 5.64 9 5.63 1 4.76 4 6.06 1 5.26 0.996**
Muscle tension 3 1.13 1 0.63 1 4.76 — — 1 5.26 0.183**
HAVE YOU PRACTICED THE TECHNIQUE AT
HOME?
Week 1 254 95.49 156 97.50 21 100.00 60 90.91 17 89.47 0.060**
Week 2 257 96.62 156 97.50 21 100.00 62 93.94 18 94.74 0.359**
Week 3 254 95.49 156 97.50 21 100.00 60 90.91 17 89.47 0.060**
Week 4 254 95.49 156 97.50 21 100.00 60 90.91 17 89.47 0.060**
HOW MANY TIMES HAVE YOU PRACTICED
THE TECHNIQUE PER WEEK?
Week 1 Mean [SD] 254 6.57
[4.36]
156 6.24
[4.05]
21 5.10
[3.13]
60 8.40
[5.17]
17 6.36
[3.45]
< .001***
Week 2 Mean [SD] 257 6.45
[3.62]
156 6.36
[3.45]
21 5.43
[2.96]
62 7.56
[4.27]
18 4.67
[2.06]
0.002***
Week 3 Mean [SD] 254 6.25
[3.57]
156 6.03
[3.39]
21 5.48
[2.87]
60 7.58
[4.17]
17 4.41
[2.18]
0.004***
Week 4 Mean [SD] 254 6.19
[3.63]
156 6.00
[3.45]
21 5.24
[2.96]
60 7.45
[4.32]
17 4.65
[2.42]
0.005***
a SD: Standard deviation
*Kruskal Wallis Test
**LR—Chi-Squared Test
***Chi-Squared Test
https://doi.org/10.1371/journal.pone.0184147.t001
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FACT-G overall and subscale scores. There was a significant increase in the mean total score
from 55.33±10.42 to 64.49±7.70 (mean change: 9.13±5.38 points, W = 16806; p<0.001).
Stratifying scores by subscales showed a significant increase in all subscales: emotional well-
being (KW = 13118; p<0.001); functional wellbeing (KW = 16155.5; p<0.001); physical well-
being (KW = 8885.5; p<0.001); and social/family context (KW = −1840; p = 0.037). S3 and S4
Figs show the graphical description of the progression of FACT-G scores.
Table 3 shows the rate score of the FACT-G, stratified by subscales and clusters.
Table 2. Variation rates of the FACT-G questionnaire for the total sample.
N Mean SDa p *
TOTAL SCORE Baseline 272 55.33 10.42 < .001
1-month follow-up 266 64.49 7.70
Rate of score 266 0.18 0.13
PHYSICAL WELL-BEING Baseline 272 17.33 4.33 < .001
1-month follow-up 266 18.71 4.02
Rate of score 266 0.08 0.08
SOCIAL/FAMILY WELL-BEING Baseline 272 18.34 4.38 0.037
1-month follow-up 266 18.11 3.83
Rate of score 266 -0.01 0.11
EMOTIONAL WELL-BEING Baseline 272 7.64 3.21 < .001
1-month follow-up 266 11.55 2.21
Rate of score 266 0.31 0.31
FUNCTIONAL WELL-BEING Baseline 272 12.03 5.13 < .001
1-month follow-up 266 16.12 4.41
Rate of score 266 0.28 0.19
* Wilcoxon Signed Rank Test
aSD: Standard deviation
https://doi.org/10.1371/journal.pone.0184147.t002
Table 3. Variation rate of the FACT-G questionnaire scores, total and subscales, stratified by clusters.
TOTAL SCORE PHYSICAL
WELL-BEING
SOCIAL/FAMILY
WELL-BEING
EMOTIONAL
WELL-BEING
FUNCTIONAL
WELL-BEING
N Mean SDa Mean SDa Mean SDa Mean SDa Mean SDa
Baseline cluster 1 160 53.04 9.64 17.19 4.63 17.61 4.10 6.58 2.28 11.66 5.24
cluster 2 21 52.86 9.34 17.33 3.53 16.57 5.16 7.24 2.95 11.71 4.63
cluster 3 66 60.33 10.07 17.18 4.05 19.94 4.13 10.47 3.54 12.74 4.68
cluster 4 19 60.44 11.92 18.79 3.68 21.12 4.52 7.79 3.31 12.74 5.38
1-month follow-up cluster 1 160 63.76 7.56 18.53 4.18 17.34 3.55 11.91 2.17 15.98 4.36
cluster 2 21 63.62 7.26 18.43 3.47 17.81 4.81 11.14 2.13 16.24 3.66
cluster 3 66 65.32 7.85 18.74 3.80 19.36 3.34 10.76 2.00 16.45 4.76
cluster 4 19 68.72 7.77 20.47 3.72 20.51 4.61 11.74 2.68 16.00 4.61
Variation rate cluster 1 160 0.22 0.12 0.08 0.09 -0.02 0.11 0.44 0.19 0.30 0.20
cluster 2 21 0.23 0.16 0.06 0.04 0.09 0.15 0.34 0.27 0.30 0.18
cluster 3 66 0.09 0.09 0.09 0.07 -0.03 0.10 0.01 0.34 0.23 0.16
cluster 4 19 0.16 0.13 0.08 0.06 -0.04 0.09 0.29 0.41 0.23 0.19
p < .001* 0.417* < .001* < .001* 0.056*
*Kruskall Wallis test: Variation rate among clusters.
aSD: Standard deviation.
https://doi.org/10.1371/journal.pone.0184147.t003
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Statistically significant differences were detected for the change rate score of the FACT-G
according to cluster (KW = 51.84; p<0.001), with the lowest rate score in cluster 3. According
to the overall scores, we detected a greater change rate score in cluster 1 (0.22±0.12) and cluster
2 (0.23±0.16), and lower rate scores in cluster 4 (0.16±0.13) and cluster 3 (0.09±0.09) (KW = 47;
p<0.001). Further, we observed that the mean initial scores for clusters 1 and 2 were the lowest
in the ensemble of data. S3 Table displays the progression of the FACT-G scores and statistical
significance of over-represented characteristics in the clusters.
Discussion
The present study indicates that patients with cancer with symptoms of anxiety who received a
protocol of abbreviated progressive muscle relaxation training [34] improved their perceived
quality of life, as measured by the FACT-G. Patients who performed the technique experienced
an increase in overall quality of life as well as in emotional, functional, and physical wellbeing.
Our findings are consistent with previous reports that concluded CAM techniques (including
relaxation techniques) can improve the quality of life of patients with cancer [11,18–25].
Beard et al. [22] investigated the effects of reiki and muscle relaxation in 54 patients with
prostate cancer. Patients received two reiki sessions plus one muscle relaxation session per
week for 8 consecutive weeks. The latter was also recommended to be practiced daily at home.
Although those authors did not find differences in overall FACT-G scores, statistically signifi-
cant improvements were detected in emotional wellbeing. Interestingly, in our study, the
FACT-G emotional wellbeing subscale showed the greatest improvement. Andersen et al. [18]
analyzed the effects of a 6-week program of exercises and muscle relaxation in 213 patients
undergoing chemotherapy treatment. In that study, the combination of high and low intensity
physical exercises and relaxation exercises did not produce significant changes in FACT-G
scores [18]. Isa et al. [23,24] studied the effect of progressive muscle relaxation on anxiety in a
group of 155 patients with prostate cancer. They found statistically significant improvements
in quality of life at 4 and 6 months, measured with the 36-item Short Form Health Survey.
Another study on mindfulness also demonstrated improvements in quality of life, particu-
larly in emotional wellbeing [39]. U¨lger et al. [20] concluded that yoga practiced for 8 weeks by
patients with cancer significantly improved energy levels, pain, emotional levels, sleep, social
adaptation, and social skills. Another study involving yoga, in which women surviving breast
cancer performed yoga five times a week for 6 months, showed improved quality of life and
decreased abdominal perimeter [25]. Finally, Bar Sela et al. [11] published a study on comple-
mentary techniques (including relaxation) involving 163 oncological patients undergoing
active treatment, and found significant improvements in quality of life (measured with the
EORTC QLQ-C30 questionnaire) and in symptoms such as nausea, pain, and insomnia.
The strengths of our study include the inclusion of a large sample from different hospitals
(multicenter study) and thorough training of research staff in performing the technique. How-
ever, potential limitations should also be considered. First, the lack of a control group represents
the main limitation of this study, and does not allow determination that the results obtained
were exclusively due to our intervention. However, a control/placebo group including patients
with cancer was difficult to include from an ethical perspective. Second, recruitment for this
study took place in hospitals via informative flyers, posters, and direct information provided by
health professionals caring for the patients. Therefore, we do not know the total number of pro-
spective participants who were informed of the study or the number of those who did not have
access to this information. Third, we only evaluated short-term effects of the intervention and
cannot determine long-term effects. Nevertheless, as several cancer types included in the present
study have high mortality, longer term information may be difficult to obtain in future studies.
Muscle relaxation in cancer patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0184147 October 19, 2017 9 / 13
Conclusions
Correct learning and regular use of progressive muscle relaxation techniques in the abbrevi-
ated version as described by Bernstein and Borkovec [34] contributes to short-term improve-
ments in the perceived quality of life of patients with cancer.
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